Modernizing drug discovery informatics with AI and machine learning
August 7, 2025, 08:00 BST / 09:00 CEST / 15:00 CST / 16:00 JST
Reliance on informatic platforms in drug discovery has become essential for managing complex data, generating actionable insights, and improving decision-making across every stage of development. Now, with the integration of AI and machine learning (ML), informatics is advancing even further to revolutionize pharmaceutical R&D.
Join our exciting line up of speakers with Dr. Barry Bunin, CEO, Collaborative Drug Discovery, Dr. Dimitris Agrafiotis, Director of Digital Analytics & AI, Arsenal Capital Partners, and Dr. Chris Waller, VP and Chief Scientist, EPAM Systems, for an expert discussion on how AI and ML have transformed drug discovery informatics to support both academic labs and global organizations.
Plus, watch a demonstration of CDD Vault's AI capabilities. Janice Darlington, Customer Engagement Scientist at CDD, will showcase practical applications in drug discovery workflows.
Key learning objectives:
- Understand current trends in pharmaceutical informatics and how they impact different organizational scales.
- Evaluate strategies for implementing and integrating modern informatics solutions with legacy systems.
- Assess the role of AI/ML technologies in drug discovery and their practical implementation.
- Identify key considerations for selecting and deploying informatics platforms in pharmaceutical R&D.
Who should attend?
- Industry professionals: Pharma R&D experts, including drug chemists, biologists, data scientists, AI/ML specialists, and informatics leads.
- Academics and strategic leaders: Computational and informatics scientists, lab directors, research managers, and VP-level executives driving R&D strategy and informatics investment decisions.
Certificate of attendance
If you attend the live webinar, you will automatically receive a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
If you view the on-demand webinar, you can request a certificate of attendance by emailing editor@selectscience.net.
Speakers
Dr. Barry Bunin is the CEO and Founder of Collaborative Drug Discovery (CDD), specializing in modern cloud-based informatics solutions for drug discovery. His industry experience spans both computational and experimental drug discovery, with significant contributions to the development of open-source descriptors and models that demonstrated comparable performance to commercial solutions. He holds a PhD in Chemistry from UC Berkeley and completed his postdoctoral research at Caltech.
Dr. Dimitris Agrafiotis is the Director of Digital Analytics and AI at Arsenal Capital Partners, specializing in technology development and artificial intelligence applications in drug discovery. He completed his postdoctoral studies at Harvard University and holds a PhD in Theoretical Chemistry from Imperial College London. Previously, he served as Chief Digital Officer at Generata Biosciences and Vice President of Digital Research and Development at Covance, where he led transformation initiatives in pharmaceutical R&D.
Dr. Chris Waller is the VP and Chief Scientist at EPAM Systems, specializing in life sciences informatics strategy and technology development. Dr. Waller holds advanced degrees in life sciences informatics and has over 30 years of experience in strategic planning and organizational development. Previously, he served as Executive Director at a large global pharmaceutical organization, where he led scientific modeling platforms and real-world evidence initiatives. His industry experience includes leadership roles in enterprise architecture and healthcare informatics, where he advanced the use of electronic medical records and personal health record data to inform research and development efforts.
Moderator
